ESPE Abstracts (2019) 92 FC9.2

Heterozygous Insulin Receptor (INSR) Mutation associated with Neonatal Hyperinsulinaemic Hypoglycaemia and Familial Diabetes Mellitus

Aashish Sethi1, Syed Haris Ahmed2, Kevin Colclough3, Mohammed Didi1, Sarah Flanagan3, Senthil Senniappan1


1Alder Hey Children Hospital, Liverpool, United Kingdom. 2Countess of Chester Hospital, Chester, United Kingdom. 3University of Exeter Medical School, Exeter, United Kingdom


Introduction: Mutations in Insulin Receptor (INSR) is usually associated with insulin resistance and hyperglycemia. Homozygous or compound heterozygous mutations in INSR are usually linked with Rabson-Mendenhall or Donohue syndromes whilst heterozygous INSR mutations are associated with type A insulin resistance. Various autosomal dominant heterozygous INSR mutations leading to hyperinsulinemic hypoglycemia (HH) have been described in adults and children but not in the neonatal period. The youngest age reported with HH and heterozygous INSR mutation is 3 years.

Case Presentation: A small for gestational age (SGA) child born to a mother with gestational diabetes presented with persistent neonatal hypoglycemia and was diagnosed with HH. The child's maternal grandfather had been diagnosed with type 2 diabetes mellitus at the age of 45 years and was treated with metformin. A good response to diazoxide was noted in the infant and on subsequent follow up, diazoxide was gradually weaned and discontinued by 8 months of age. The couple's second child presented with SGA and HH at birth responsive to diazoxide which remitted at 10 months of age. Both infants tolerated a 16 hour fast without hypoglycemia and with normal concentrations of plasma insulin and demonstrated no clinical evidence of insulin resistance at 2 and 4 years of age. The mother had normal body mass index (BMI 24 kg/m2). Maternal grandfather of the infants had a BMI of 25 kg/m2. Neither adult showed clinical signs of insulin resistance. On genetic analysis, a heterozygous pathogenic INSR missense variant p.(Met1180Lys) was found in both infants, mother and grandfather, but not in the father.

Conclusion: We report, for the first time, an association between INSR mutation and transient neonatal HH. INSR mutations should be considered in patients with neonatal HH and a family history of diabetes mellitus. Follow up of these children is important to determine the natural history of progression and early diagnosis of diabetes or insulin resistance.

Article tools

My recent searches

No recent searches.